Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2025-12-24 @ 2:41 PM
NCT ID:
NCT04453059
Eligibility Criteria:
Patients will be included in the study if:
* Demographic and safety data are available for analysis
* Complete set of CT images performed after oral administration of Isovue-300 are available for assessment
* Isovue-300 was orally administered during an interval time of 60-20 minutes before the CT scanning.
Patients will be excluded from the study if:
* Oral contrast agent received within 1 week prior to the CT scan
* Undergone any abdominopelvic surgery procedure that resulted in alteration of the bowel transit time prior to the CT exam
* CT exam with oral administration of Isovue was performed because of a known or suspected condition of bowel obstruction
* Patient did not actively drink the contrast solution.
Sex:
ALL
Study:
NCT04453059
Study Brief:
Protocol Section:
NCT04453059